ArticleJournal of virology2002

Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection.

Richard B Pyles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.